ATE273698T1 - Systeme zur arzneistoffabgabe an schleimhäute - Google Patents

Systeme zur arzneistoffabgabe an schleimhäute

Info

Publication number
ATE273698T1
ATE273698T1 AT99954718T AT99954718T ATE273698T1 AT E273698 T1 ATE273698 T1 AT E273698T1 AT 99954718 T AT99954718 T AT 99954718T AT 99954718 T AT99954718 T AT 99954718T AT E273698 T1 ATE273698 T1 AT E273698T1
Authority
AT
Austria
Prior art keywords
mucous
measures
delivery
systems
mucosal
Prior art date
Application number
AT99954718T
Other languages
English (en)
Inventor
Charles J Matson
Yen-Lane Chen
Daniel T Ruth
Luce R M Benes
Sophie G Burgaud
Francoise L R Horriere
Isabelle M L Seyler
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Application granted granted Critical
Publication of ATE273698T1 publication Critical patent/ATE273698T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT99954718T 1998-10-02 1999-10-01 Systeme zur arzneistoffabgabe an schleimhäute ATE273698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10295698P 1998-10-02 1998-10-02
PCT/US1999/022967 WO2000019987A1 (en) 1998-10-02 1999-10-01 Mucosal originated drug delivery systems and animal applications

Publications (1)

Publication Number Publication Date
ATE273698T1 true ATE273698T1 (de) 2004-09-15

Family

ID=22292601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954718T ATE273698T1 (de) 1998-10-02 1999-10-01 Systeme zur arzneistoffabgabe an schleimhäute

Country Status (19)

Country Link
EP (1) EP1117390B1 (de)
JP (1) JP2002526403A (de)
KR (1) KR20010075528A (de)
CN (1) CN1321086A (de)
AT (1) ATE273698T1 (de)
AU (1) AU768040B2 (de)
BR (1) BR9915020A (de)
CA (1) CA2345808A1 (de)
CZ (1) CZ20011188A3 (de)
DE (1) DE69919554T2 (de)
ES (1) ES2228125T3 (de)
HU (1) HUP0103543A2 (de)
IL (1) IL142168A0 (de)
MX (1) MXPA01003310A (de)
NO (1) NO20011656L (de)
NZ (1) NZ510771A (de)
PL (1) PL347061A1 (de)
PT (1) PT1117390E (de)
WO (1) WO2000019987A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
JP5043435B2 (ja) 2003-10-03 2012-10-10 スリーエム イノベイティブ プロパティズ カンパニー アルコキシ置換イミダゾキノリン
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
FI20041425A0 (fi) 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
JP2006335640A (ja) * 2005-05-06 2006-12-14 Daicho Kikaku:Kk 動物用薬剤
RU2414193C2 (ru) * 2005-07-29 2011-03-20 Сантен Фармасьютикал Ко., Лтд. Неинвазивная система доставки лекарственного средства к ткани заднего сегмента глаза с применением твердой композиции
EP2023908A1 (de) * 2006-03-07 2009-02-18 Oramelts International, INC. Mehrschichtiges medizinisches pflaster mit undurchlässigem zentrum
EP3067044B1 (de) * 2006-07-21 2019-03-27 BioDelivery Sciences International, Inc. Vorrichtungen zur transmukosalen abgabe mit verbesserter aufnahme
DE102008011800A1 (de) 2008-02-29 2009-10-15 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
BRPI1010567A2 (pt) * 2009-05-15 2016-03-15 Recro Pharma Inc composições sublinguais de dexmedetomidina e métodos de uso e aparelho que os emprega
WO2011008958A1 (en) * 2009-07-17 2011-01-20 The Board Of Regents For Oklahoma State University Supralingual vaccines and applicators
EP2570217B1 (de) 2011-09-15 2014-11-05 Klingelnberg AG Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
KR20160055934A (ko) * 2013-10-07 2016-05-18 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정성 덱스메데토미딘 경피 조성물을 사용하여 금단 증후군을 치료하기 위한 방법 및 조성물
TWI645866B (zh) 2013-10-07 2019-01-01 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
US20150098997A1 (en) 2013-10-07 2015-04-09 Teikoku Pharma Usa, Inc. Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions
KR101891186B1 (ko) * 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 포함하는 통증을 관리하기 위한 방법 및 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
GB1455251A (en) * 1972-08-25 1976-11-10 Evode Ltd Method of sealing gaps and compositions therefor heat
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2712807B1 (fr) * 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine

Also Published As

Publication number Publication date
CN1321086A (zh) 2001-11-07
NO20011656D0 (no) 2001-04-02
KR20010075528A (ko) 2001-08-09
DE69919554T2 (de) 2005-09-01
IL142168A0 (en) 2002-03-10
DE69919554D1 (de) 2004-09-23
EP1117390B1 (de) 2004-08-18
AU768040B2 (en) 2003-11-27
MXPA01003310A (es) 2003-05-15
NO20011656L (no) 2001-04-02
BR9915020A (pt) 2001-08-14
PL347061A1 (en) 2002-03-11
CZ20011188A3 (cs) 2001-08-15
EP1117390A1 (de) 2001-07-25
PT1117390E (pt) 2005-01-31
HUP0103543A2 (hu) 2002-01-28
ES2228125T3 (es) 2005-04-01
CA2345808A1 (en) 2000-04-13
WO2000019987A1 (en) 2000-04-13
JP2002526403A (ja) 2002-08-20
AU1100100A (en) 2000-04-26
NZ510771A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
ATE273698T1 (de) Systeme zur arzneistoffabgabe an schleimhäute
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
GEP20053602B (en) Aripiprazole for Oral Administration
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE527010T1 (de) Vorrichtung zur verabreichung von co
IL174525A0 (en) Medicamentously targeted local lipolysis
DE60236639D1 (de) Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
GB0130677D0 (en) Medicaments and novel compounds
ATE226094T1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE222109T1 (de) Kombiniertes therapeutisches verfahren zur behandlung von hyperproliferativen krankheiten
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
UA31156A (uk) Спосіб лікування пневмоентеритів телят
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "
HUP9903911A2 (hu) PKC inhibitorok alkalmazása a központi idegrendszer HIV-fertőzéssel kapcsolatos megbetegedéseinek kezelésére szolgáló gyógyászati készítmények előállítására
ES2148063A1 (es) Proteina hibrida para utilizar en la liberacion dirigida de un compuesto a uan celula humana o animal.
ECSP951424A (es) Procedimiento para la administracion de azitromicina
RU94020597A (ru) Способ лечения псевдотуберкулеза

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1117390

Country of ref document: EP

REN Ceased due to non-payment of the annual fee